Justin Oldham, MD, MS, provides clinical insights on the evolving treatment landscape in idiopathic pulmonary fibrosis.
October 17th 2024EP. 11: Overview of Idiopathic Pulmonary Fibrosis (IPF)
Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) is a specific form of interstitial lung disease characterized by progressive lung scarring, which leads to significant respiratory impairment and distinct clinical challenges compared with other interstitial lung diseases.
October 17th 2024EP. 12: Impact of IPF on Quality of Life and Financial Considerations
Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) severely affects patients’ quality of life and daily functioning, with a median survival that underscores the disease’s severity, while also highlighting the substantial financial burden and health care resource utilization associated with managing this condition.